Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.6%

1 terminated/withdrawn out of 28 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

29%

8 trials in Phase 3/4

Results Transparency

13%

2 of 15 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A
7(31.8%)
Phase 3
6(27.3%)
Phase 2
4(18.2%)
Phase 1
3(13.6%)
Phase 4
2(9.1%)
22Total
N/A(7)
Phase 3(6)
Phase 2(4)
Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT05512169Recruiting

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Role: collaborator

NCT06962202Recruiting

Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT

Role: collaborator

NCT05925946Not ApplicableNot Yet Recruiting

Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM

Role: collaborator

NCT02513888Not ApplicableCompleted

Prevention of Type 2 Diabetes With Vitamin D Supplementation

Role: collaborator

NCT02513875Not ApplicableCompleted

Prevention of Type 2 Diabetes With Vitamin D

Role: collaborator

NCT00439660Phase 1Completed

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Role: collaborator

NCT04623606Phase 1Unknown

Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones

Role: collaborator

NCT00123669Phase 2Completed

Primary Progesterone Therapy for Operable Breast Cancer

Role: collaborator

NCT01616693Phase 4Completed

Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines

Role: collaborator

NCT03180138Not ApplicableCompleted

Enhancing Health Care Access With Cellular Technology

Role: collaborator

NCT00278746Not ApplicableCompleted

Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting

Role: collaborator

NCT02425670Phase 2Completed

Stem Cell Therapy For Acute Ischemic Stroke Patients

Role: collaborator

NCT02116920Unknown

HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening

Role: collaborator

NCT00265226Phase 3Completed

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

Role: lead

NCT00341328Phase 3Completed

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

Role: lead

NCT00128817Phase 3Terminated

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Role: collaborator

NCT01305109Phase 3Unknown

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E

Role: collaborator

NCT01278719Unknown

The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study

Role: collaborator

NCT01508533Completed

Epidemiology of Rotavirus Infection in North India Community

Role: collaborator

NCT01501773Phase 2Completed

Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke

Role: collaborator